GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Issuance of Stock

Clearmind Medicine (Clearmind Medicine) Issuance of Stock : $3.50 Mil (TTM As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Issuance of Stock?

Clearmind Medicine's Issuance of Stock for the three months ended in Jan. 2024 was $1.83 Mil.

Clearmind Medicine's Issuance of Stock for the trailing twelve months (TTM) ended in Jan. 2024 was $3.50 Mil.

Clearmind Medicine Issuance of Stock Historical Data

The historical data trend for Clearmind Medicine's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Issuance of Stock Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Issuance of Stock
Get a 7-Day Free Trial - 0.45 4.35 0.43 8.04

Clearmind Medicine Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.36 0.46 0.19 1.02 1.83

Clearmind Medicine Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clearmind Medicine Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Issuance of Stock
Comparable Companies
TSXV:MRVL TSX:IPCI XCNQ:GLOW XCNQ:BIOV XCNQ:NOVA XCNQ:NIRV XCNQ:BRAX TSXV:WAVE XCNQ:MBIO TSX:APLI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
CWY0:Germany CWY0:Germany CMND:Canada
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Website
https://www.clearmindmedicine.com
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.